LS Covid19

COVID-19 and the Life Sciences industry

10 jun 2020

The COVID-19 pandemic has dramatically impacted many aspects of life. The extent of the effects still needs to be fully understood. But some impacts to the Life Sciences M&A market are already visible. Across all industries many transactions have been put on hold, as parties are concentrating on the continuity of their businesses. While some of those deals will be closed later this year, many will be stalled. The shortage of debt financing, the investment controlling regulation by the German government and purchase price disputes might reduce the number of transactions even more. In this worldwide downturn of the economy, Life Sciences companies will not be immune, but they show more resilience than other sectors.

The trend of Life Sciences companies focusing on their core businesses is now more visible than ever, as we see increased spin-offs and divestitures. We also expect increasing institutional investments in the Life Sciences sector. With less targets on the market, those opportunities will become more competitive.

As the pandemic is forcing us to go online, the trend towards digitalisation will see an immense acceleration. Changes that for long have seemed impossible due to strict regulations and cultural aversions, are now happening, including telehealth and sick leave notes via phone. Patients and providers have learned to manage the distance and use digital tools. The enormous costs burdening the providers as a consequence of the shutdowns will further drive digitalisation to dramatically increase productivity.

COVID -19 will eventually lead to a re-thinking of supply chains. China holds a central role as manufacturer, producing 90% of active pharmaceutical ingredients, thus leading to fear of shortages and dependencies. Some countries have limited their export of medical products. Businesses in the future will be required to have detailed planning on how to overcome short term supply issues. This aspect will also have a strong impact on the pricing in M&A transactions.

Most Medtech and pharma companies remained stable throughout the pandemic, while healthcare provider businesses are having difficulties. With many specialty doctor’s offices being closed, and hospitals concentrating on COVID-19 patients and emergencies rather than performing revenue-driving surgeries, the healthcare provider segment sees decreasing revenues and increasing losses. The full extent of the SARS CoV-2 virus on the Life Sciences industry will have to be evaluated at the end of the pandemic, but with the exception of provider businesses M&A activities will remain on high levels at comparably high prices.

Team

Bild av Michael Moritz
Michael Moritz

Managing Partner

Telefon: +49 30 809 33 47-13

LinkedIn

@

Bild av Mark Miller
Mark Miller

Managing Partner

Telefon: +49 40 300 836-11

LinkedInXING

@

Bild av Caspar Graf Stauffenberg
Caspar Graf Stauffenberg

Managing Partner

Telefon: +49 89 255 49 53-11

LinkedIn

@

Bild av Daniel Garlipp
Daniel Garlipp

Managing Partner

Telefon: +49 40 300 836-19

LinkedIn

@

Bild av Daniel Dies
Daniel Dies

Partner

Telefon: +49 40 300 836-16

LinkedIn

@

Bild av Manfred Drax
Manfred Drax

Partner

Telefon: +49 89 255 49 53-15

LinkedIn

@

Bild av Nico Schmidt-Weidemann
Nico Schmidt-Weidemann

Partner

Telefon: +49 89 255 49 53-17

@

Bild av Anders Elgemyr
Anders Elgemyr

Managing Partner

Telefon: +46 70 496 18 15

LinkedIn

@

Bild av Erik Lundberg
Erik Lundberg

Director

Telefon: +46 73 850 35 59

LinkedIn

@

Bild av Arnold Holle
Arnold Holle

Managing Partner

Telefon: +44 20 80176020

LinkedIn

@

Bild av Anders Bo
Anders Bo

Managing Partner

Telefon: +45 4199 8252

LinkedIn

@

Bild av Flemming C. Pedersen
Flemming C. Pedersen

Managing Partner

Telefon: +45 4199 8251

LinkedIn

@

Bild av Morten Kjærulff
Morten Kjærulff

Partner

Telefon: +45 2634 9031

LinkedIn

@

Bild av Kurfürstendamm 188
Kurfürstendamm 188

10707 Berlin

Telefon: +49 30 809 334 70

LinkedIn

@

Bild av Michael Moritz
Michael Moritz

Managing Partner

Telefon: +49 30 809 33 47-13

LinkedIn

@

Bild av Eva Macha
Eva Macha

Office Management

Telefon: +49 30 809 33 47-10

LinkedIn

@

Bild av Jessica Algner
Jessica Algner

Office Management

Telefon: +49 30 809 33 47-12

LinkedIn

@

Bild av Nils Zettelmeyer
Nils Zettelmeyer

Director

Telefon: +49 30 809 33 47-25

LinkedIn

@

Bild av Thorsten Grandt
Thorsten Grandt

Vice President

Telefon: +49 30 809 33 47-20

LinkedIn

@

Bild av Toldbodgade 57
Toldbodgade 57

1253 Copenhagen K

Telefon: +45 3945 0010

LinkedIn

@

Bild av Anders Bo
Anders Bo

Managing Partner

Telefon: +45 4199 8252

LinkedIn

@

Bild av Flemming C. Pedersen
Flemming C. Pedersen

Managing Partner

Telefon: +45 4199 8251

LinkedIn

@

Bild av Morten Kjærulff
Morten Kjærulff

Partner

Telefon: +45 2634 9031

LinkedIn

@

Bild av Esplanade 41
Esplanade 41

20354 Hamburg

Telefon: +49 40 300 83 60

LinkedIn

@

Bild av Mark Miller
Mark Miller

Managing Partner

Telefon: +49 40 300 836-11

LinkedInXING

@

Bild av Daniel Garlipp
Daniel Garlipp

Managing Partner

Telefon: +49 40 300 836-19

LinkedIn

@

Bild av Daniel Dies
Daniel Dies

Partner

Telefon: +49 40 300 836-16

LinkedIn

@

Bild av Anna-Lena Kickbusch
Anna-Lena Kickbusch

Office Management & Accounting

Telefon: +49 40 300 836 10

LinkedIn

@

Bild av Elaine Kelly
Elaine Kelly

PR, Marketing & Business Development Manager

Telefon: +49 40 300 836 18

LinkedIn

@

Bild av Mischa Krause
Mischa Krause

Director

Telefon: +49 40 300 836-24

LinkedIn

@

Bild av 14 Buckingham Street
14 Buckingham Street

London WC2N 6DF

Telefon: +44 20 8017 6020

LinkedIn

@

Bild av Arnold Holle
Arnold Holle

Managing Partner

Telefon: +44 20 80176020

LinkedIn

@

Bild av Jon Tingling
Jon Tingling

Associate

Telefon: +44 77 1347-8286

LinkedIn

@

Bild av Von-der-Tann-Straße 7
Von-der-Tann-Straße 7

80539 München

Telefon: +49 89 255 495 30

LinkedIn

@

Bild av Caspar Graf Stauffenberg
Caspar Graf Stauffenberg

Managing Partner

Telefon: +49 89 255 49 53-11

LinkedIn

@

Bild av Manfred Drax
Manfred Drax

Partner

Telefon: +49 89 255 49 53-15

LinkedIn

@

Bild av Nico Schmidt-Weidemann
Nico Schmidt-Weidemann

Partner

Telefon: +49 89 255 49 53-17

@

Bild av Anika Schaefer
Anika Schaefer

Office Management & HR

Telefon: +49 89 255 495 310

@

Bild av Birger Jarlsgatan 13
Birger Jarlsgatan 13

111 45 Stockholm

Telefon: +46 8 684 439 00

LinkedIn

@

Bild av Anders Elgemyr
Anders Elgemyr

Managing Partner

Telefon: +46 70 496 18 15

LinkedIn

@

Bild av Erik Lundberg
Erik Lundberg

Director

Telefon: +46 73 850 35 59

LinkedIn

@

Bild av Caroline Berglund
Caroline Berglund

Strategic Business Manager

Telefon: +46 73 382 10 82

LinkedIn

@

Bild av Johan Heigard
Johan Heigard

Vice President

Telefon: +46 70 246 99 88

LinkedIn

@

Bild av Erik Foberg
Erik Foberg

Director ECM

Telefon: +46 70 434 85 03

LinkedIn

@

Bild av Markus Augustsson
Markus Augustsson

Head of Equity Research

Telefon: +46 76 235 03 20

LinkedIn

@

Bild av Bertil Nilsson
Bertil Nilsson

Senior Equity Analyst

Telefon: +46 70 434 90 03

LinkedIn

@

Bild av Richard Ramanius
Richard Ramanius

Associate Equity Analyst

Telefon: +46 73 539 66 99

LinkedIn

@

Bild av Lars Johansen
Lars Johansen

IT&Telecom Expert

@

Bild av Ulf Boberg
Ulf Boberg

Senior Advisor Life Science

Telefon: +46 73 312 44 90

LinkedIn

@